Rigel Pharmaceuticals
RIGL
$1.10
Share price
0.00%
Change (1 day)
-2.65%
Change (1 year)
Categories
Rigel Pharmaceuticals (RIGL) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.14 B
According to Rigel Pharmaceuticals's latest financial reports the company's total liabilities are $0.14 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Rigel Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.14 B | -1.37% |
| 2022-12-31 | $0.14 B | 7.99% |
| 2021-12-31 | $0.13 B | 79.37% |
| 2020-12-31 | $76.35 M | -18.56% |
| 2019-12-31 | $93.75 M | 220.72% |
| 2018-12-31 | $29.23 M | 58.31% |
| 2017-12-31 | $18.46 M | -20.09% |
| 2016-12-31 | $23.1 M | -42.76% |
| 2015-12-31 | $40.36 M | 55.92% |
| 2014-12-31 | $25.88 M | 45.39% |
| 2013-12-31 | $17.8 M | -14.99% |
| 2012-12-31 | $20.94 M | -0.05% |
| 2011-12-31 | $20.95 M | 1.91% |
| 2010-12-31 | $20.56 M | -33.4% |
| 2009-12-31 | $30.87 M | -22.21% |
| 2008-12-31 | $39.69 M | 18.11% |
| 2007-12-31 | $33.6 M | 29.2% |
| 2006-12-31 | $26.01 M | -33.44% |
| 2005-12-31 | $39.08 M | 47.35% |
| 2004-12-31 | $26.52 M | 70.54% |
| 2003-12-31 | $15.55 M | -17.72% |
| 2002-12-31 | $18.9 M | 7.96% |
| 2001-12-31 | $17.5 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $90.92 B | 62,231.27% | 🇺🇸 USA |
 AstraZeneca AZN | $64.79 B | 44,317.94% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | $82.43 M | -43.49% | 🇺🇸 USA |